Stock ALERS EUROBIO SCIENTIFIC
Add to a list
To use this feature you must be a member
Log inSign up

All News Eurobio Scientific

Equities

ALERS

FR0013240934

Real-time Euronext Paris
Other stock markets
 04:09:57 2024-05-10 am EDT 		5-day change 1st Jan Change
14.54 EUR -1.49% Intraday chart for Eurobio Scientific +0.28% -11.66%
May. 08 Eurobio Scientific: agreement with Myriad Genetics CF
May. 08 Eurobio Scientific to Buy Gene Expression Test for Breast Cancer MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Eurobio Scientific: agreement with Myriad Genetics
CF
Eurobio Scientific to Buy Gene Expression Test for Breast Cancer
MT
EUROBIO SCIENTIFIC SIGNS AN AGREEMENT TO ACQUIRE GENE EXPRESSION TEST FOR BREAST CANCER ENDOPREDICT®
GL
Eurobio Scientific Société anonyme signed a definitive agreement to acquire EndoPredict business of Myriad Genetics, Inc for $10 million.
CI
Eurobio Scientific: 2023 results down, share price falls
CF
EUROBIO SCIENTIFIC: 2023 ANNUAL RESULTS
GL
Eurobio Scientific Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Eurobio Scientific: FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUP
GL
Eurobio Scientific: FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUP
AQ
Eurobio Scientific Société anonyme acquired Alpha Biotech Ltd.
CI
Eurobio Scientific: cancellation of treasury shares
CF
OSE Immunotherapeutics Announces a Collaboration Agreement with GenDx for the Development of a Companion Diagnostic for Epitope-Based Cancer Vaccine Candidate Tedopi
AQ
OSE Immuno: collaboration agreement with GenDx
CF
Eurobio Scientific: CATHERINE COURBOILLET TO JOIN EUROBIO SCIENTIFIC BOARD AS AN INDEPENDENT MEMBER
GL
Eurobio Scientific: CATHERINE COURBOILLET TO JOIN EUROBIO SCIENTIFIC BOARD AS AN INDEPENDENT MEMBER
AQ
Eurobio Scientific Appoints Catherine Courboillet to the Board of Directors
CI
Interim report 1 January - 30 September 2023
AQ
Eurobio Scientific - MISE À DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2023
GL
Eurobio Scientific - MISE À DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2023
AQ
Eurobio Scientific: GenDx reduces organ matching time to 3 hours
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALERS Stock
  4. News Eurobio Scientific
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW